These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20076805)

  • 21. Corrigendum: Changes in Blood Factors and Ultrasound Findings in Mild Cognitive Impairment and Dementia.
    Cho K; Kim J; Kim GW
    Front Aging Neurosci; 2018; 10():33. PubMed ID: 29485141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
    Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU
    J Neurol; 2008 Feb; 255(2):255-64. PubMed ID: 18204803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erratum: An Erratum to Correct Typographical Errors.
    Ann Rehabil Med; 2016 Oct; 40(5):959. PubMed ID: 27847729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erratum: An Erratum to Correct Typographical Errors.
    Ann Rehabil Med; 2016 Dec; 40(6):1151. PubMed ID: 28119849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.
    Derejko M; Sławek J; Wieczorek D; Brockhuis B; Dubaniewicz M; Lass P
    Nucl Med Commun; 2006 Dec; 27(12):945-51. PubMed ID: 17088679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological study.
    Smith CR; Cullen B; Sheridan MP; Cavanagh J; Grosset KA; Grosset DG
    Acta Neurol Scand; 2020 Jun; 141(6):500-508. PubMed ID: 32002988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Be vigilant for dementia in Parkinson’s disease.
    Niccolini F; Diamantopoulos K; Kiosses S; Politis M
    Practitioner; 2017 May; 261(1804):11-5. PubMed ID: 29120562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic functional connectivity changes associated with dementia in Parkinson's disease.
    Fiorenzato E; Strafella AP; Kim J; Schifano R; Weis L; Antonini A; Biundo R
    Brain; 2019 Sep; 142(9):2860-2872. PubMed ID: 31280293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erratum: A practical approach to detection and treatment of depression in Parkinson disease and dementia.
    Neurol Clin Pract; 2018 Aug; 8(4):278. PubMed ID: 30140576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erratum to "Distinct Neural Correlates of Executive Function by Amyloid Positivity and Associations with Clinical Progression in Mild Cognitive Impairment" by Yoon HJ, et al. (Yonsei Med J 2019;60(10):935-943.).
    Yonsei Med J; 2020 May; 61(5):445. PubMed ID: 32390370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corrigendum: White Matter Changes-Related Gait and Executive Function Deficits: Associations with Age and Parkinson's Disease.
    Sartor J; Bettecken K; Bernhard FP; Hofmann M; Gladow T; Lindig T; Ciliz M; Ten Kate M; Geritz J; Heinzel S; Benedictus M; Scheltens P; Hobert MA; Maetzler W
    Front Aging Neurosci; 2017; 9():342. PubMed ID: 29056907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erratum: Apathy and functional disability in behavioral variant frontotemporal dementia.
    Neurol Clin Pract; 2018 Jun; 8(3):185. PubMed ID: 30105156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible role of glial cell line-derived neurotrophic factor for predicting cognitive impairment in Parkinson's disease: a case-control study.
    Shi MY; Ma CC; Chen FF; Zhou XY; Li X; Tang CX; Zhang L; Gao DS
    Neural Regen Res; 2021 May; 16(5):885-892. PubMed ID: 33229724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of Mild Cognitive Impairment and Dementia in Parkinson's Disease: The Parkinson's Disease Cognitive Impairment Study.
    Nicoletti A; Luca A; Baschi R; Cicero CE; Mostile G; Davì M; Pilati L; Restivo V; Zappia M; Monastero R
    Front Aging Neurosci; 2019; 11():21. PubMed ID: 30800065
    [No Abstract]   [Full Text] [Related]  

  • 36. [Subtypes of mild cognitive impairment in Parkinson's disease and factors predicting its becoming dementia].
    Toribio-Diaz ME; Carod-Artal FJ
    Rev Neurol; 2015 Jul; 61(1):14-24. PubMed ID: 26108904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and functional neuroimaging changes associated with cognitive impairment and dementia in Parkinson's disease.
    Owens-Walton C; Jakabek D; Power BD; Walterfang M; Hall S; van Westen D; Looi JCL; Shaw M; Hansson O
    Psychiatry Res Neuroimaging; 2021 Jun; 312():111273. PubMed ID: 33892387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erratum to: Conference materials. 15
    Cent Eur J Immunol; 2016; 41(4):442. PubMed ID: 28559744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erratum: A rare intracranial tumor consisting of malignant anaplastic and papillary meningioma subtypes.
    Surg Neurol Int; 2016; 7():58. PubMed ID: 27280054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing the Diagnostic Accuracy of Two Cognitive Screening Instruments in Different Dementia Subtypes and Clinical Depression.
    O'Caoimh R; Molloy DW
    Diagnostics (Basel); 2019 Aug; 9(3):. PubMed ID: 31398811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.